D.E. Shaw & Co’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.45M Sell
205,473
-120,821
-37% -$3.2M ﹤0.01% 1391
2025
Q1
$7.88M Buy
326,294
+224,051
+219% +$5.41M 0.01% 1125
2024
Q4
$4.11M Sell
102,243
-354,217
-78% -$14.3M ﹤0.01% 1414
2024
Q3
$28.9M Sell
456,460
-69,042
-13% -$4.37M 0.02% 517
2024
Q2
$27.9M Buy
525,502
+449,760
+594% +$23.8M 0.03% 464
2024
Q1
$6.21M Sell
75,742
-39,893
-34% -$3.27M 0.01% 1169
2023
Q4
$2.15M Buy
115,635
+29,655
+34% +$552K ﹤0.01% 1707
2023
Q3
$952K Sell
85,980
-244,942
-74% -$2.71M ﹤0.01% 2057
2023
Q2
$5.36M Sell
330,922
-519,133
-61% -$8.42M 0.01% 1219
2023
Q1
$14.2M Sell
850,055
-101,185
-11% -$1.68M 0.02% 749
2022
Q4
$8.94M Buy
951,240
+937,374
+6,760% +$8.81M 0.01% 1053
2022
Q3
$38K Sell
13,866
-3,434
-20% -$9.41K ﹤0.01% 3436
2022
Q2
$50K Sell
17,300
-158,978
-90% -$459K ﹤0.01% 3664
2022
Q1
$529K Buy
+176,278
New +$529K ﹤0.01% 3186
2021
Q3
Sell
-16,273
Closed -$97K 3869
2021
Q2
$97K Sell
16,273
-2,966
-15% -$17.7K ﹤0.01% 3344
2021
Q1
$122K Sell
19,239
-5,526
-22% -$35K ﹤0.01% 2850
2020
Q4
$139K Sell
24,765
-34,492
-58% -$194K ﹤0.01% 2607
2020
Q3
$345K Sell
59,257
-15,260
-20% -$88.8K ﹤0.01% 2226
2020
Q2
$537K Buy
74,517
+3,719
+5% +$26.8K ﹤0.01% 2126
2020
Q1
$331K Buy
70,798
+57,257
+423% +$268K ﹤0.01% 2300
2019
Q4
$109K Buy
+13,541
New +$109K ﹤0.01% 2564
2018
Q4
Sell
-27,426
Closed -$478K 2749
2018
Q3
$478K Sell
27,426
-74,420
-73% -$1.3M ﹤0.01% 2101
2018
Q2
$967K Buy
+101,846
New +$967K ﹤0.01% 1913